Solid Biosciences
SLDB
SLDB
104 hedge funds and large institutions have $437M invested in Solid Biosciences in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $414M → $437M (+$23.7M)
0.5% more ownership
Funds ownership: 4.29% → 4.79% (+0.5%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
104
Holding in Top 10
1
Calls
$5.35M
Puts
$2.09M
Top Buyers
| 1 | +$23.3M | |
| 2 | +$14.4M | |
| 3 | +$13.7M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$13.2M |
| 5 |
AG
Artal Group
Luxembourg
|
+$12.4M |
Top Sellers
| 1 | -$4.33M | |
| 2 | -$4.24M | |
| 3 | -$1.92M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.16M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$846K |